Total Payments
$702,459
2024 Payments
$68,454
Companies
18
Transactions
972
Medicare Patients
913
Medicare Billing
$192,094
Payment Breakdown by Category
Other$502,956 (71.6%)
Travel$120,415 (17.1%)
Consulting$56,911 (8.1%)
Food & Beverage$22,161 (3.2%)
Education$15.32 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $481,706 | 240 | 68.6% |
| Travel and Lodging | $120,415 | 351 | 17.1% |
| Consulting Fee | $56,911 | 20 | 8.1% |
| Food and Beverage | $22,161 | 345 | 3.2% |
| Honoraria | $21,250 | 14 | 3.0% |
| Education | $15.32 | 2 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ACADIA Pharmaceuticals Inc | $298,331 | 443 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $123,610 | 151 | $0 (2019) |
| SANOFI-AVENTIS U.S. LLC | $116,536 | 115 | $0 (2018) |
| Neurocrine Biosciences, Inc. | $101,545 | 133 | $0 (2024) |
| Sun Pharmaceutical Industries Inc. | $20,760 | 28 | $0 (2022) |
| Sunovion Pharmaceuticals Inc. | $19,708 | 59 | $0 (2021) |
| Collegium Pharmaceutical, Inc. | $7,627 | 12 | $0 (2018) |
| Sanofi Pasteur Inc. | $4,562 | 12 | $0 (2018) |
| Qiagen, LLC | $3,907 | 3 | $0 (2021) |
| CMP Pharma, Inc. | $3,100 | 2 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $68,454 | 131 | ACADIA Pharmaceuticals Inc ($36,351) |
| 2023 | $101,540 | 159 | ACADIA Pharmaceuticals Inc ($69,607) |
| 2022 | $99,124 | 109 | ACADIA Pharmaceuticals Inc ($57,557) |
| 2021 | $44,275 | 53 | ACADIA Pharmaceuticals Inc ($31,567) |
| 2020 | $30,844 | 39 | ACADIA Pharmaceuticals Inc ($25,920) |
| 2019 | $92,596 | 144 | ACADIA Pharmaceuticals Inc ($77,328) |
| 2018 | $34,460 | 47 | Janssen Pharmaceuticals, Inc ($25,224) |
| 2017 | $231,166 | 290 | SANOFI-AVENTIS U.S. LLC ($110,987) |
All Payment Transactions
972 individual payment records from CMS Open Payments — Page 1 of 39
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | Travel and Lodging | In-kind items and services | $246.87 | General |
| Category: PARKINSONS DISEASE PSYCHOSIS | ||||||
| 12/19/2024 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: PARKINSONS DISEASE PSYCHOSIS | ||||||
| 12/18/2024 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | Travel and Lodging | In-kind items and services | $70.00 | General |
| Category: PARKINSONS DISEASE PSYCHOSIS | ||||||
| 12/18/2024 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | Travel and Lodging | In-kind items and services | $65.67 | General |
| Category: PARKINSONS DISEASE PSYCHOSIS | ||||||
| 12/18/2024 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | Travel and Lodging | In-kind items and services | $37.72 | General |
| Category: PARKINSONS DISEASE PSYCHOSIS | ||||||
| 12/18/2024 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | Food and Beverage | In-kind items and services | $31.19 | General |
| Category: PARKINSONS DISEASE PSYCHOSIS | ||||||
| 12/18/2024 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | Food and Beverage | In-kind items and services | $27.60 | General |
| Category: PARKINSONS DISEASE PSYCHOSIS | ||||||
| 12/18/2024 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | Travel and Lodging | In-kind items and services | $20.10 | General |
| Category: PARKINSONS DISEASE PSYCHOSIS | ||||||
| 12/12/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Consulting Fee | Cash or cash equivalent | $4,687.50 | General |
| Category: Neuropsychiatry | ||||||
| 12/12/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Travel and Lodging | In-kind items and services | $70.00 | General |
| Category: Neuropsychiatry | ||||||
| 12/12/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Travel and Lodging | In-kind items and services | $20.10 | General |
| Category: Neuropsychiatry | ||||||
| 12/12/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $12.58 | General |
| Category: Neuropsychiatry | ||||||
| 12/11/2024 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,000.00 | General |
| Category: PARKINSONS DISEASE PSYCHOSIS | ||||||
| 12/11/2024 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | Travel and Lodging | In-kind items and services | $1,224.33 | General |
| Category: PARKINSONS DISEASE PSYCHOSIS | ||||||
| 12/11/2024 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | Travel and Lodging | In-kind items and services | $138.69 | General |
| Category: PARKINSONS DISEASE PSYCHOSIS | ||||||
| 12/07/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Travel and Lodging | In-kind items and services | $303.97 | General |
| Category: Neuropsychiatry | ||||||
| 12/07/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $60.57 | General |
| Category: Neuropsychiatry | ||||||
| 12/07/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $40.37 | General |
| Category: Neuropsychiatry | ||||||
| 12/07/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $35.72 | General |
| Category: Neuropsychiatry | ||||||
| 12/07/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $34.72 | General |
| Category: Neuropsychiatry | ||||||
| 12/03/2024 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,100.00 | General |
| Category: PARKINSONS DISEASE PSYCHOSIS | ||||||
| 11/26/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Travel and Lodging | In-kind items and services | $1,519.96 | General |
| Category: Neuropsychiatry | ||||||
| 11/23/2024 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | Food and Beverage | In-kind items and services | $122.06 | General |
| Category: PARKINSONS DISEASE PSYCHOSIS | ||||||
| 11/14/2024 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | Travel and Lodging | In-kind items and services | $184.62 | General |
| Category: PARKINSONS DISEASE PSYCHOSIS | ||||||
| 11/14/2024 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | Travel and Lodging | In-kind items and services | $65.00 | General |
| Category: PARKINSONS DISEASE PSYCHOSIS | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 3 | 81 | 345 | $56,059 | $21,025 |
| 2022 | 7 | 339 | 1,119 | $202,312 | $70,183 |
| 2021 | 7 | 295 | 1,003 | $148,703 | $65,418 |
| 2020 | 6 | 198 | 524 | $49,803 | $35,468 |
Total Patients
913
Total Services
2,991
Medicare Billing
$192,094
Procedure Codes
23
All Medicare Procedures & Services
23 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99308 | Subsequent nursing facility care with straightforward level of medical decision making, per day, if using time, at least 15 minutes | Facility | 2023 | 52 | 316 | $51,650 | $19,278 | 37.3% |
| 99309 | Subsequent nursing facility care with moderate level of medical decision making, per day, if using time, at least 30 minutes | Facility | 2023 | 13 | 13 | $2,769 | $1,192 | 43.0% |
| 99307 | Subsequent nursing facility care with straightforward level of medical decision making, per day, if using time, at least 10 minutes | Facility | 2023 | 16 | 16 | $1,639 | $555.04 | 33.9% |
| 99308 | Follow-up nursing facility visit per day, typically 15 minutes | Facility | 2022 | 139 | 709 | $115,886 | $38,989 | 33.6% |
| 99336 | Established patient custodial care facility, group care, or assisted living visit, typically 40 minutes | Office | 2022 | 38 | 93 | $29,153 | $10,642 | 36.5% |
| 99334 | Established patient custodial care facility, group care, or assisted living visit, typically 15 minutes | Office | 2022 | 33 | 130 | $18,485 | $6,563 | 35.5% |
| 99335 | Established patient custodial care facility, group care, or assisted living visit, typically 25 minutes | Office | 2022 | 35 | 62 | $13,760 | $4,956 | 36.0% |
| 99305 | Initial nursing facility visit per day, typically 35 minutes | Facility | 2022 | 32 | 39 | $11,684 | $4,157 | 35.6% |
| 99309 | Follow-up nursing facility visit per day, typically 25 minutes | Facility | 2022 | 32 | 41 | $8,734 | $3,192 | 36.6% |
| 99307 | Follow-up nursing facility visit per day, typically 10 minutes | Facility | 2022 | 30 | 45 | $4,611 | $1,683 | 36.5% |
| 99308 | Subsequent nursing facility visit, typically 15 minutes per day | Facility | 2021 | 87 | 538 | $70,194 | $32,427 | 46.2% |
| 99336 | Established patient assisted living visit, typically 40 minutes | Office | 2021 | 36 | 75 | $20,523 | $8,744 | 42.6% |
| 99334 | Established patient assisted living visit, typically 15 minutes | Office | 2021 | 43 | 154 | $19,726 | $7,825 | 39.7% |
| 99335 | Established patient assisted living visit, typically 25 minutes | Office | 2021 | 34 | 66 | $12,183 | $5,350 | 43.9% |
| 99309 | Subsequent nursing facility visit, typically 25 minutes per day | Facility | 2021 | 30 | 54 | $9,944 | $4,196 | 42.2% |
| 99307 | Subsequent nursing facility visit, typically 10 minutes per day | Facility | 2021 | 44 | 95 | $8,419 | $3,525 | 41.9% |
| 99327 | New patient assisted living visit, typically 60 minutes | Office | 2021 | 21 | 21 | $7,715 | $3,351 | 43.4% |
| 99308 | Subsequent nursing facility visit, typically 15 minutes per day | Facility | 2020 | 63 | 285 | $23,073 | $16,185 | 70.1% |
| 99336 | Established patient assisted living visit, typically 40 minutes | Office | 2020 | 30 | 64 | $10,000 | $7,375 | 73.8% |
| 99335 | Established patient assisted living visit, typically 25 minutes | Office | 2020 | 42 | 91 | $10,186 | $7,347 | 72.1% |
| 99309 | Subsequent nursing facility visit, typically 25 minutes per day | Facility | 2020 | 25 | 33 | $3,504 | $2,451 | 69.9% |
| 99334 | Established patient assisted living visit, typically 15 minutes | Office | 2020 | 17 | 22 | $1,536 | $1,139 | 74.2% |
| 99307 | Subsequent nursing facility visit, typically 10 minutes per day | Facility | 2020 | 21 | 29 | $1,505 | $970.48 | 64.5% |
About Dr. Albert Riddle, MD
Dr. Albert Riddle, MD is a Geriatric Medicine healthcare provider based in Haworth, New Jersey. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/08/2006. The National Provider Identifier (NPI) number assigned to this provider is 1699724880.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Albert Riddle, MD has received a total of $702,459 in payments from pharmaceutical and medical device companies, with $68,454 received in 2024. These payments were reported across 972 transactions from 18 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($481,706).
As a Medicare-enrolled provider, Riddle has provided services to 913 Medicare beneficiaries, totaling 2,991 services with total Medicare billing of $192,094. Data is available for 4 years (2020–2023), covering 23 distinct procedure/service records.
Ad
Practice Information
- Specialty Geriatric Medicine
- Location Haworth, NJ
- Active Since 05/08/2006
- Last Updated 01/24/2008
- Taxonomy Code 207RG0300X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1699724880
Products in Payments
- NUPLAZID (Drug) $298,331
- XARELTO (Drug) $123,495
- TOUJEO (Drug) $107,207
- INGREZZA (Drug) $101,545
- DRIZALMA SPRINKLE (Drug) $11,250
- SOLIQUA (Drug) $9,329
- BROVANA (Drug) $8,324
- EZALLOR SPRINKLE (Drug) $8,239
- Xtampza ER (Drug) $7,627
- UTIBRON (Drug) $5,738
- FLUZONE HIGH-DOSE (Drug) $4,050
- LONHALA MAGNAIR (Drug) $2,832
- KYNMOBI (Drug) $2,800
- KAPSPARGO (Drug) $1,256
- Carospir (Drug) $750.00
- NO PRODUCT DISCUSSED (Drug) $512.22
- INVOKANA (Drug) $114.99
- NAMZARIC (Drug) $32.17
- REXULTI (Drug) $29.17
- VARITHENA (Drug) $21.87
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.